The effects of alpha-methyl-3, 4-dihydroxy-L-phenylalanine (methyldopa, Aldomet) on erythrocytes.
D000743:Anemia, Hemolytic / Q000139:chemically induced*; D001665:Binding Sites; D003298:Coombs Test; D004912:Erythrocytes / Q000187:drug effects*; D006386:Hemagglutination Tests; D006452:Hemoglobinometry; D006460:Hemolysin Proteins; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008750:Methyldopa / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D009504:Neutrophils; D009996:Osmotic Fragility; D012156:Reticulocytes; D012204:Rh-Hr Blood-Group System
D006460:Hemolysin Proteins; D012204:Rh-Hr Blood-Group System; D008750:Methyldopa